Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 1999, p. 1030-1034, Vol. 37, No. 4
National Center for Infectious Diseases,
Centers for Disease Control and Prevention, Public Health Service,
U.S. Department of Health and Human Services, Atlanta, Georgia
303331; Department of Gynecologic
Oncology, University of Texas M. D. Anderson Cancer Center,
Houston, Texas 770302; and Division
of Cancer Control and Population Science, National Cancer
Institute, Bethesda, Maryland 20892-73443
Received 4 December 1998/Returned for modification 8 January
1999/Accepted 22 January 1999
The association between human papillomavirus (HPV) DNA copy number
and cervical disease was investigated. Viral DNA copy number for the
most common high-risk HPV types in cervical cancer (types 16, 18, 31, and 45) was determined in cervical cytobrush specimens from 149 women
with high-grade cervical intraepithelial neoplasias (CIN II-CIN III),
176 with low-grade CIN (CIN I), and 270 with normal cytology.
Quantitative, PCR-based fluorescent assays for each of the HPV
genotypes and for the
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Papillomavirus (HPV) DNA Copy Number Is
Dependent on Grade of Cervical Disease and HPV Type
-globin gene were used. The amount of cellular
DNA increased significantly with increasing disease; thus, HPV was
expressed as copies per microgram of cellular DNA. The assay had a
dynamic range of >107, allowing documentation for the
first time of the wide range of HPV copy numbers seen in clinical
specimens. Median HPV DNA copy number varied by more than
104 among the viral types. HPV16 was present in the highest
copy number; over 55% of HPV16-positive samples contained more than 108 copies/µg. Median copy number for HPV16 showed
dramatic increases with increasing epithelial abnormality, an effect
not seen with the other HPV types. HPV16 increased from a median of
2.2 × 107 in patients with normal cytology, to
4.1 × 107 in CIN I patients, to 1.3 × 109 copies/µg in CIN II-III patients. Even when
stratified by cervical disease and viral type, the range of viral DNA
copies per microgram of cellular DNA was quite large, precluding
setting a clinically significant cutoff value for "high" copy
numbers predictive of disease. This study suggests that the clinical
usefulness of HPV quantitation requires reassessment and is assay dependent.
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, Mail Stop G-18, 1600 Clifton Rd.,
Atlanta, GA 30333. Phone: (404) 639-1300. Fax: (404) 639-0049. E-mail: dcs1{at}cdc.gov.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|